After news that Zantac had been linked to increased levels of a potential human carcinogen, many patients taking the drug began to see a possible link between using ranitidine or Zantac and their cancer. Many former ranitidine users have filed for Zantac cancer claiming the drug was the direct cause of their disease.
However, there are so many people in America who filed a lawsuit against Zantac, in which four victims filed generic Zantac lawsuits against Sanofi-Aventis U.S. and Boehringer Ingelheim. They claim that not only is there outright deception and an inability to protect consumers from extremely high levels of NDMA, but they also claim that the extent to which the Zantac brand is capable of producing NDMA in the body is extremely dangerous and abusive.
Image Source: Google
While manufacturers and the FDA have acknowledged the evidence of ranitidine's ability as a possible human carcinogen, many believe they realized the dangers too late and did not warn the public early enough. For those who believe that Zantac caused cancer, many worry that this delay has allowed patients to develop higher levels of NDMA, and this is a grave violation of their obligation to protect society.
Does Zantac Really Cause Cancer?
Studies are underway to determine the relationship between ranitidine-containing products, including Zantac, in different types of cancer. While many are waiting for research to conclusively prove this, people are reporting cases of Zantac cancer on a case-by-case basis. While each case is unique and the relationship should be clear, some of the cancers listed in Zantac's compensation claim are:
- Stomach cancer
- Bladder cancer
- Small bowel cancer
- Colon cancer
- Kidney cancer
- Heart cancer
- Esophageal cancer
- Prostate cancer
- Pancreatic cancer